Erratum

In the article by Y. Huang et al., entitled “Enhanced Tumor Suppression by a p14ARF/p53 Bicistronic Adenovirus through Increased p53 Protein Translation and Stability,” which appeared in the July 1, 2003 issue of Cancer Research ( pp. 3646–3653 ), the second sentence of the abstract appeared incorrectly as “The accumulation and activity of p53 are positively controlled by the p14 ADP p14ARF ribosylation factor (AR) tumor suppressor, and full restoration of the pathway in cancer cells may require that both p53 and p14ARF be supplied.” The correct sentence is “The accumulation and activity of p53 are positively controlled by the p14ARF tumor suppressor, and full restoration of the pathway in cancer cells may require that both p53 and p14ARF be supplied.” Also, “ADP ribosylation factor” should not have been included in Footnote 3. The correct Footnote 3 is “The abbreviations used are: ARF, alternate reading frame; CMV, cytomegalovirus; pfu, plaque-forming unit(s); m.o.i., multiplicities of infection; GFP, green fluorescent protein; FACS, fluorescence-activated cell sorter; RT-PCR, reverse transcriptase-PCR.”